Cargando…
Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer’s Disease Therapeutic Development
As genome-wide association studies (GWAS) have grown in size, the number of genetic variants that have been associated per disease has correspondingly increased. Despite this increase in the number of single-nucleotide polymorphisms (SNPs) identified per disease, their biological interpretation has...
Autores principales: | Nevado-Holgado, Alejo J., Ribe, Elena, Thei, Laura, Furlong, Laura, Mayer, Miguel-Angel, Quan, Jie, Richardson, Jill C., Cavanagh, Jonathan, Lovestone, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562942/ https://www.ncbi.nlm.nih.gov/pubmed/31072055 http://dx.doi.org/10.3390/cells8050425 |
Ejemplares similares
-
Comorbidity between Alzheimer’s disease and major depression: a behavioural and transcriptomic characterization study in mice
por: Martín-Sánchez, Ana, et al.
Publicado: (2021) -
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
por: Nevado-Holgado, Alejo J, et al.
Publicado: (2016) -
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer’s disease
por: Winchester, Laura M., et al.
Publicado: (2018) -
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
por: Rojo, Ana I., et al.
Publicado: (2017) -
ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset
por: Birkenbihl, Colin, et al.
Publicado: (2021)